4 Results for "

CDK2-Cyclin E1

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CDK2-Cyclin E1" in MCE Product Catalog:

5
5 Cited Publications
Cat. No.: HY-137894A
CAS No.: 2733575-91-0
Purity:  99.95%
Synonyms: PF-07104091 hydrate
Target:  

CDK GSK-3

Research Areas:  

Cancer

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N3389
CAS No.: 66056-19-7
Licoisoflavone A is an orally active isoflavone. Licoisoflavone A inhibits proliferation, induces apoptosis, and causes G1/S phase arrest in colorectal cancer (CRC) cells. Licoisoflavone A inhibits the CDK2-Cyclin E1 axis. Licoisoflavone A inhibits lipid peroxidation with an IC50 of 7.2 μM. Licoisoflavone A shows a dose-dependent inhibition effect on SARS-CoV-2 infection. Licoisoflavone A exhibits significant anti-tumor efficacy in mice bearing CT26 cell subcutaneous xenografts. Licoisoflavone A can be used for the study of colorectal cancer and SARS-CoV-2 infection [1] [2] .
loading...
    loading...
Cat. No.: HY-170897
CAS No.: 3065079-44-6
Target:  

CDK

Research Areas:  

Cancer

CDK2-IN-40 is a CDK2 (Cyclin dependent kinase 2) inhibitor, extracted from patent WO 2024/254245 A1 (Example 1). CDK2-IN-40 inhibits CDK2/Cyclin E1 with an IC50 of ≤ 10 nM [1].
loading...
    loading...
Cat. No.: HY-160643
CAS No.: 2927473-94-5
Target:  

CDK

Research Areas:  

Cancer

CDK2-IN-27 (compound 1) is a potent CDK2 inhibitor with IC50 values of <10, >10-20 nM for CDK2/cyclin E1, CDK2/cyclin B1, respectively [1].
loading...
    loading...